RAYOS
Drug
Horizon Pharma plc
Total Payments
$4.7M
Transactions
47,302
Doctors
9,357
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2023 | $111.81 | 6 | 2 |
| 2022 | $301,624 | 5,331 | 2,331 |
| 2021 | $365,162 | 6,261 | 2,592 |
| 2020 | $425,572 | 6,101 | 2,203 |
| 2019 | $1.0M | 7,853 | 2,089 |
| 2018 | $1.2M | 10,744 | 2,677 |
| 2017 | $1.4M | 11,006 | 2,899 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $3.5M | 2,013 | 73.9% |
| Food and Beverage | $815,741 | 44,109 | 17.2% |
| Travel and Lodging | $217,028 | 1,014 | 4.6% |
| Unspecified | $177,253 | 12 | 3.7% |
| Grant | $15,825 | 2 | 0.3% |
| Consulting Fee | $10,730 | 1 | 0.2% |
| Education | $517.00 | 151 | 0.0% |
Payments by Type
General
$4.6M
47,290 transactions
Research
$177,253
12 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| HNZP-PRE-IIT-004 | Horizon Pharma plc | $177,253 | 0 |
Top Doctors Receiving Payments for RAYOS — Page 3
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , D.O | Rheumatology | Warwick, RI | $22,680 | 28 |
| , DO | Rheumatology | Wexford, PA | $21,731 | 123 |
| , M.D | Rheumatology | Turlock, CA | $20,830 | 115 |
| , MD | Rheumatology | Merrillville, IN | $20,512 | 114 |
| , M.D | Rheumatology | El Cajon, CA | $19,268 | 67 |
| , M.D | Rheumatology | Dallas, TX | $18,547 | 48 |
| , D.O | Physical Medicine & Rehabilitation | New York, NY | $17,107 | 85 |
| , M.D | Rheumatology | Fayetteville, NC | $16,899 | 49 |
| , MD | Rheumatology | Floral Park, NY | $16,771 | 65 |
| , DO | Rheumatology | Coeur D'alene, ID | $16,627 | 29 |
| , M.D | Rheumatology | Fullerton, CA | $16,155 | 46 |
| , DPM | Podiatrist | Durham, NC | $15,887 | 58 |
| , MD | Rheumatology | Los Alamitos, CA | $15,107 | 40 |
| , MD | Allergy & Immunology | San Antonio, TX | $14,005 | 16 |
| , D.O | Internal Medicine | Houston, TX | $13,606 | 30 |
| , M.D | Specialist | Chula Vista, CA | $13,066 | 47 |
| , M.D | Rheumatology | Biloxi, MS | $12,567 | 52 |
| , M.D | Rheumatology | Houston, TX | $12,235 | 16 |
| , MD, PHD | Rheumatology | San Antonio, TX | $12,064 | 27 |
| Michael Colin | Rheumatology | New York, NY | $11,836 | 62 |
| , D.O | Pain Medicine | Richmond, VA | $11,808 | 72 |
| , M.D | Rheumatology | Goodyear, AZ | $11,278 | 51 |
| , M.D | Rheumatology | Myrtle Beach, SC | $11,033 | 49 |
| , M.D | Rheumatology | Boston, MA | $10,730 | 1 |
| , M.D | Rheumatology | Santa Rosa, CA | $10,324 | 49 |
Ad
Manufacturing Companies
- Horizon Pharma plc $2.6M
- Horizon Therapeutics plc $2.1M
Product Information
- Type Drug
- Total Payments $4.7M
- Total Doctors 9,357
- Transactions 47,302
About RAYOS
RAYOS is a drug associated with $4.7M in payments to 9,357 healthcare providers, recorded across 47,302 transactions in the CMS Open Payments database. The primary manufacturer is Horizon Pharma plc.
Payment data is available from 2017 to 2023. In 2023, $111.81 was paid across 6 transactions to 2 doctors.
The most common payment nature for RAYOS is "Honoraria" ($3.5M, 73.9% of total).
RAYOS is associated with 1 research study, including "HNZP-PRE-IIT-004" ($177,253).